ウィークリー トップ トラック
- 男
- ソーシャルリンク
- 彼がいた
-
The authors conducted a retrospective analysis of 6,355 Medicare beneficiaries who had at least 1 testosterone injection (mean number of injections over the entire study period 8.2) and matched them to 19,065 men who were testosterone therapy naïve for the preceding 12 months. Despite the homogenous nature of the trials included, it was noted that there was a risk of publication bias since it is possible that trials favoring testosterone therapy might remain unpublished. Included in these events were 33 deaths, 22 of which were in men who were on testosterone therapy, and 11 in the placebo groups.
One important aspect of study design is the specific endpoints and objective measures used to identify outcomes. Readers should recognize that guideline statements have been generalized in an attempt to provide a clinically useful document with the understanding that certain populations and clinical scenarios will fall outside of the initial criteria upon which the studies were based. Individual study factors, such as the heterogeneity and demographics of the study population, the comorbidities of the study population and how they are controlled in the analysis, and confidence intervals also impact overall study quality. Meta-analyses that are limited to only including RCTs may be restricted to a small number of studies and relevant studies may be excluded that could provide sufficient power to make alternative conclusions. For example, outcomes of meta-analyses using RCTs alone are generally more robust than those that also include cohort studies. When reviewing results from meta-analyses, it is important to recognize that the overall reliability is dependent on the quality of the weakest study included in the analysis.
Total testosterone absence of signs and/or symptoms increases the likelihood of making a false diagnosis and reduces the potential benefit of testosterone therapy. Likewise, while some literature suggests that food ingestion might affect testosterone levels, the evidence is particularly weak, and the Panel does not recommend that clinicians insist on fasting prior to testing. Among men with traditional (10p.m. to 6a.m.) sleep patterns, peak testosterone values occur around 3-8a.m., with 32-39% of the diurnal total decline occurring within the first 30 minutes of waking.18-23 Older men experience diurnal blunting and more stability in testosterone levels throughout the day, while younger men undergo greater variation. Likewise, while some literature suggests that food ingestion might affect testosterone levels, the evidence is particularly weak, and the Panel does not recommend that clinicians insist on fasting prior to testing.Circadian Rhythm. Given the growing concern and need for proper testosterone therapy, the AUA identified a need to produce an evidence-based document that informs clinicians on the proper evaluation and management of testosterone deficient patients. Testosterone levels should be measured every 6-12 months while on testosterone therapy. PSA should be measured in men over 40 years of age prior to commencement of testosterone therapy to exclude a prostate cancer diagnosis.
A review by Millar et al.4 searched MEDLINE and Embase databases from January 1966 to July 2014 for studies that compared clinical indication of low testosterone along with a measurement of serum testosterone in men. Considering the inherent confusion surrounding testosterone therapy in the current prescribing landscape, the AUA believes it is imperative to be as explicit as possible and present the reader the most complete information, which will optimize the efficacy and safety of testosterone therapy. The AUA nomenclature system explicitly links statement type to body of evidence strength, level of certainty, magnitude of benefit or risk/burdens, and the Panel's judgment regarding the balance between benefits and risks/burdens (Table 1 - See button below). Testosterone therapy refers to all forms of treatment that are aimed at increasing serum testosterone, including exogenous testosterone as well as alternative strategies, such as selective estrogen receptor modulators (SERMs), human chorionic gonadotropin (hCG) or aromatase inhibitors (AIs). The Panel explicitly uses the term testosterone therapy rather than testosterone replacement therapy or testosterone supplementation to be in keeping with the beliefs of the current thought leaders in the field. Thus, a patient is considered testosterone deficient and a candidate for testosterone therapy only when he meets both criteria. Ultimately, the AUA and the Testosterone Panel were committed to creating a Guideline that ensures that men in need of testosterone therapy are treated effectively and safely.
A low or low/normal LH level points to a secondary (central) hypothalamic-pituitary defect, (hypogonadotropic hypogonadism), while an elevated LH level indicates a primary testicular defect (hypergonadotropic hypogonadism).168 In men with hypogonadotropic hypogonadism, the yield from adjunctive tests (e.g., prolactin measurement, pituitary imaging, iron studies) is increased. Screening questionnaires are not an appropriate tool to identify candidates for testosterone therapy. A survey of 120 patients who were treated for infertility at the University of Illinois-Chicago found that the incidence of testosterone deficiency was 45% in men with non-obstructive azoospermia, 42.9% in men with oligospermia, and 16.7% in men with obstructive azoospermia.159 There does appear to be a trend towards lower total testosterone and a diagnosis of ED. Given that the direct method for free testosterone measurement is also time-consuming and labor intensive, calculation derived free testosterone measurement is more commonly used, however there is considerable variation in total testosterone assays as well as the clinical conditions that affect serum albumin and SHBG, all of which impact this measurement. The Panel recommends that clinicians use the same laboratory with the same method/instrumentation for serial total testosterone measurement. There is a great deal of variability across studies with respect to the forms of testosterone measured (total versus free), the assays utilized to measure testosterone, the time of day when the sample is obtained, and the number of testosterone measurements taken.
At this time, identification of the optimal patient (based on age, varicocele grade, baseline testosterone level) has not been defined.75 There are inherent challenges in testosterone measurement due to the health status of patients at the time of testing, circadian rhythms in testosterone production, intra-individual variability, and inconsistencies in the assays themselves. The Panel does not recommend using free testosterone measurements as the primary diagnostic method for testosterone deficiency. Some authorities have advocated that free testosterone should be the primary measure used to define testosterone deficiency. Due to the challenges in testosterone methodology, there is considerable variability in testosterone reference ranges.13 The specific reference ranges used to diagnose testosterone deficiency are discussed in more depth later in this document.
With TRT, you take a manufactured form of testosterone to regulate your levels. TRT involves taking manufactured forms of testosterone to regulate your levels of this hormone. Testosterone replacement therapy (TRT) can help improve the symptoms of low testosterone due to male hypogonadism. If you’re concerned about your testosterone level, you and your doctor can go over your medications to make sure that’s not the problem and make adjustments to your treatment. Before starting TRT, your doctor should assess your risk for prostate cancer.
Lifestyle changes, such as exercise, improving diet, and maintaining a moderate weight, may have a more significant effect than taking these supplements. However, there is typically little evidence to demonstrate their effectiveness. They may also wish to ask about the potential costs and benefits of their particular medical history and their need to explore suitable alternatives. These may be more convenient for a person to take, but they can also increase the chances of irritation or infection. These injections will typically be either testosterone enanthate or testosterone cypionate, which people use every 1 to 2 weeks. A person may receive testosterone injections from their doctor, or a healthcare professional might allow them to inject themselves at home.
This condition can be worsened by testosterone replacement. For many men, their prostates grow larger as they age, squeezing the tube carrying urine (urethra). Testosterone also increases bone density, muscle mass, and insulin sensitivity in some men. One downside is that these pills are expensive and may not be covered by insurance, unless you've tried other methods of treatment and had no success or bad side effects. - http://47.94.55.54:3000/elverachristy
